Prevalence of Clinically Relevant UGT1A Alleles and Haplotypes in African Populations

Evidence for Higher Red Blood Cell Mass in Persons With Unconjugated Hyperbilirubinemia and Gilbert’s Syndrome

(2009) Yahya Buyukasik et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Analysis of inherited genetic variations at theUGT1locus in the French-Canadian population

(2009) Vincent Ménard et al.   HUMAN MUTATION

Gilbert’s syndrome and hyperbilirubinemia in protease inhibitor therapy – An extended haplotype of genetic variants increases risk in indinavir treatment

(2009) Tim O. Lankisch et al.   JOURNAL OF HEPATOLOGY

(TA)n UDP-Glucuronosyltransferase 1A1 Promoter Polymorphism in Nigerian Neonates

(2009) Michael Kaplan et al.   PEDIATRIC RESEARCH

UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia

(2008) Shannon L. Carpenter et al.   AMERICAN JOURNAL OF HEMATOLOGY

Gilbert's Syndrome and Irinotecan Toxicity: Combination with UDP-Glucuronosyltransferase 1A7 Variants Increases Risk

(2008) T. O. Lankisch et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa

(2008) Krishna R. Veeramah et al.   Pharmacogenetics and Genomics

Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species

(2007) Sanjay Kumar et al.   FREE RADICAL BIOLOGY AND MEDICINE